24 May 2013
Keywords: ERYTECH Pharma, Orphan designation, Enhoxy, Graspa, EMA
Article | 14 June 2012
French late-stage biopharma company ERYTECH Pharma says that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 June 2012
13 June 2012
23 May 2013
© 2013 thepharmaletter.com